Top 9 manufacturers in Morphine Sulfat (CAS 64-31-3) Market
By Prof Researh
Updated 12:20:21 October 18, 2019
.
Updated 12:20:21 October 18, 2019
Prof Resear published a new Market report on Morphine Sulfat (CAS 64-31-3) Market. It present the largest 9 manufacruers in Morphine Sulfat (CAS 64-31-3) Market. The report is a professional and in-depth study on the current state of the global Morphine Sulfat (CAS 64-31-3) market with a focus on the Chinese market. The report provides key statistics on market of Morphine Sulfat (CAS 64-31-3). It is a valuable source of guidance and direction for companies and individuals interested in Morphine Sulfat (CAS 64-31-3) industry.
.
Mallinckrodt Pharmaceuticals
Ref A: CED918DDC5BD4C5A92904632BED99F3B Ref B: SJCEDGE0415 Ref C: 2019-10-18T04:20:02Z
Alcaliber
Ref A: 61E33D749DDD435DBAC1D304C25D3C05 Ref B: SJCEDGE0414 Ref C: 2019-10-18T04:20:04Z
Purdue Pharma
Ref A: EE2D3655637B4F89BBEB729F263DB0A3 Ref B: SJCEDGE0417 Ref C: 2019-10-18T04:20:06Z
Cepia-Sanofi
Sanofi CEPiA CEPiA is a worldwide organization of 200 experienced professionals, dedicated to the customer’s needs and the market specificities. Categories Manufacturing Operating Status Active CEPiA-Sanofi CEPiA-Sanofi is a supplier of Active Pharmaceutical Ingredients (APIs) and Intermediates. To meet the needs of its customers, Sanofi has created a specific organization within its Industrial Affairs: CEPiA (Commercial and External Partnership Industrial Affairs). CEPiA Sales is a Sanofi activity dedicated to manufacturing and supply of a broad range of APIs available on a catalogue basis. By employing its exhaustive industrial capabilities, facilities and expertise expected of large pharma , CEPiA provides its clients with «fast to market» solutions.
Macfarlan Smith
Ref A: 326ECB83E0D649469DD8D199AE913616 Ref B: SJCEDGE0411 Ref C: 2019-10-18T04:20:14Z
SUN PHARMA
Ref A: 097518A37ED443398D2F3EA0E998FD08 Ref B: SJCEDGE0419 Ref C: 2019-10-18T04:20:15Z
Qinghai Pharmaceutical
Ref A: E726727754074E9F9AECABBE6411AC76 Ref B: SJCEDGE0222 Ref C: 2019-10-18T04:20:17Z
Taj Pharmaceuticals
We at Taj Pharmaceuticals Limited India are committed to our customers and employees and, more importantly, to the people who rely on our medicines. We plan to move forward with greater vigour and a clearer vision to put each and every individual at the heart of our commitment, working for healthier India – health. With the creation of Taj ... TAJ Pharmaceuticals Limited is a Non-govt company, incorporated on 05 Nov, 2004. Its a public unlisted company and is classified as company limited by shares. Companys authorized capital stands at Rs 200.0 lakhs and has 52.499996% paid-up capital which is Rs 105.0 lakhs. Tajs Mission & Profile As one of the worlds leading innovation-driven healthcare groups, whose core businesses are Pharmaceuticals and Diagnostics, Taj Pharmaceuticals aims to supply products and services that significantly improve peoples lives by helping to prevent, diagnose and treat disease.
Northeast Pharm
Ref A: B75955A3E8314EC7B3916416504E9615 Ref B: SJCEDGE0415 Ref C: 2019-10-18T04:20:20Z